Aflibercept administration in neovascular age-related macular degeneration refractory to previous anti-vascular endothelial growth factor drugs: a critical review and new possible approaches to move forward
Crossref DOI link: https://doi.org/10.1007/s10456-015-9483-4
Published Online: 2015-09-07
Published Print: 2015-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lazzeri, Stefano
Ripandelli, Guido
Sartini, Maria Sole
Parravano, Mariacristina
Varano, Monica
Nardi, Marco
Di Desidero, Teresa
Orlandi, Paola
Bocci, Guido
Funding for this research was provided by:
University of Pisa (Fondi di Ateneo)
Text and Data Mining valid from 2015-09-07